24 - Week Flibanserin 100mg for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women in Noth America
24 - Week Flibanserin 100mg for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women in Noth America
The objective of this trial is to assess the safety and efficacy of 24-week course of flibanserin for the treatment of Hypoactive Sexual Desire Disorder (HSDD) in naturally postmenopausal women.
Inclusion criteria:
Exclusion criteria:
Tuscon, Arizona, United States
Tuscon, Arizona, United States
Gainseville, Florida, United States
Mount Pearl, Newfoundland and Labrador, Canada